Syndax Pharmaceuticals's total assets for Q4 2025 were $529.71M, a decrease of -4.00% from the previous quarter. SNDX total liabilities were $465.08M for the fiscal quarter, a 6.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.